A new study from the World Health Organization finds the anti-viral drug Remdesivir has little to no effect on Covid-19 patients' chances of survival.
The drug's manufacturer has rejected the trial's findings.
US Correspondent Rachel Silverman has more.
IN: The W-H-O
OUT:SOC
DUR: 40
GENERIC: http://www.fsnradionews.com/feeds/1016remdes-rs-generic.mp3